Additional shares required to issue upon achieving development milestone.

No definition available.

Name:	eras_AdditionalSharesRequiredToIssueUponAchievingDevelopmentMilestone
Namespace Prefix:	eras_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Asset acquisitions.

+ References

No definition available.

+ Details

Name:	eras_AssetAcquisitionsLineItems
Namespace Prefix:	eras_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Future development and regulatory milestone cash payments maximum.

+ References

No definition available.

+ Details

Name:	eras_FutureDevelopmentAndRegulatoryMilestoneCashPaymentsMaximum
Namespace Prefix:	eras_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Milestones accrued.

+ References

No definition available.

+ Details

Name:	eras_MilestonesAccrued
Namespace Prefix:	eras_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Upfront payment made.

+ References

No definition available.

+ Details

Name:	eras_UpfrontPaymentMade
Namespace Prefix:	eras_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Number of shares of equity interests issued or issuable to acquire entity.

+ References

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionSharePrice
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.

+ References

No definition available.

+ Details

Name:	us-gaap_ResearchAndDevelopmentInProcess
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Number of shares issued during the period as a result of the conversion of convertible securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-30)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=eras_AsanaMergerAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=eras_SeriesB2ConvertiblePreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=eras_EmergeLifeSciencesPurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Asset Acquisitions - Additional Information (Details) - USD ($)		1 Months Ended			3 Months Ended		12 Months Ended
	Jul. 20, 2021	Jul. 31, 2021	Mar. 31, 2021	Nov. 30, 2020	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2021
Asset Acquisitions [Line Items]
In-process research and development					$ 2,000,000	$ 3,680,000
Common Stock \| IPO
Asset Acquisitions [Line Items]
Convertible preferred stock converted into shares of common stock	71,263,685	71,263,685
Asana Merger Agreement
Asset Acquisitions [Line Items]
Upfront payment made				$ 20,000,000.0
Future development and regulatory milestone cash payments maximum				$ 90,000,000.0
Additional shares required to issue upon achieving development milestone				3,888,889
In-process research and development					0	0	$ 50,000,000.0
Milestones accrued					0			$ 0
Asana Merger Agreement \| Series B-2 Convertible Preferred Stock
Asset Acquisitions [Line Items]
Shares issued				4,000,000
Value per share				$ 7.50
Total fair value				$ 30,000,000.0
Asana Merger Agreement \| Series B-2 Convertible Preferred Stock \| Common Stock \| IPO
Asset Acquisitions [Line Items]
Convertible preferred stock converted into shares of common stock				3,333,333
ELS Purchase Agreement
Asset Acquisitions [Line Items]
Upfront payment made			$ 2,000,000.0
In-process research and development					$ 0	$ 3,700,000
ELS Purchase Agreement \| Common Stock
Asset Acquisitions [Line Items]
Shares issued			500,000
Value per share			$ 3.36			$ 3.36
Total fair value			$ 1,700,000			$ 1,700,000